Celldex Therapeutics, Inc. (CLDX)

Celldex Therapeutics Statistics

Total Valuation

CLDX has a market cap or net worth of $1.63 billion. The enterprise value is $879.82 million.

Market Cap	1.63B
Enterprise Value	879.82M

Important Dates

The next estimated earnings date is Monday, February 24, 2025, before market open.

Earnings Date	Feb 24, 2025
Ex-Dividend Date	n/a

Share Statistics

CLDX has 66.34 million shares outstanding. The number of shares has increased by 28.81% in one year.

Current Share Class	66.34M
Shares Outstanding	66.34M
Shares Change (YoY)	+28.81%
Shares Change (QoQ)	+0.42%
Owned by Insiders (%)	0.28%
Owned by Institutions (%)	104.67%
Float	62.70M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	144.98
Forward PS	774.72
PB Ratio	2.01
P/TBV Ratio	2.15
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	88.19
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 24.27, with a Debt / Equity ratio of 0.00.

Current Ratio	24.27
Quick Ratio	23.58
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -29.84% and return on invested capital (ROIC) is -20.96%.

Return on Equity (ROE)	-29.84%
Return on Assets (ROA)	-19.73%
Return on Capital (ROIC)	-20.96%
Revenue Per Employee	$62,350
Profits Per Employee	-$962,981
Employee Count	160
Asset Turnover	0.02
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -39.63% in the last 52 weeks. The beta is 1.62, so CLDX's price volatility has been higher than the market average.

Beta (5Y)	1.62
52-Week Price Change	-39.63%
50-Day Moving Average	25.79
200-Day Moving Average	33.65
Relative Strength Index (RSI)	44.24
Average Volume (20 Days)	1,076,758

Short Selling Information

The latest short interest is 8.09 million, so 12.19% of the outstanding shares have been sold short.

Short Interest	8.09M
Short Previous Month	7.31M
Short % of Shares Out	12.19%
Short % of Float	12.90%
Short Ratio (days to cover)	8.96

Income Statement

In the last 12 months, CLDX had revenue of $9.98 million and -$154.08 million in losses. Loss per share was -$2.53.

Revenue	9.98M
Gross Profit	-137.06M
Operating Income	-174.18M
Pretax Income	-150.22M
Net Income	-154.08M
EBITDA	-171.06M
EBIT	-174.18M
Loss Per Share	-$2.53

Balance Sheet

The company has $756.00 million in cash and $3.09 million in debt, giving a net cash position of $752.91 million or $11.35 per share.

Cash & Cash Equivalents	756.00M
Total Debt	3.09M
Net Cash	752.91M
Net Cash Per Share	$11.35
Equity (Book Value)	785.91M
Book Value Per Share	11.85
Working Capital	746.75M

Cash Flow

In the last 12 months, operating cash flow was -$157.84 million and capital expenditures -$1.83 million, giving a free cash flow of -$159.66 million.

Operating Cash Flow	-157.84M
Capital Expenditures	-1.83M
Free Cash Flow	-159.66M
FCF Per Share	-$2.41

Margins

Gross Margin	n/a
Operating Margin	-1,745.97%
Pretax Margin	-1,544.48%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CLDX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-28.81%
Shareholder Yield	-28.81%
Earnings Yield	-9.44%
FCF Yield	-9.78%

Analyst Forecast

The average price target for CLDX is $64.83, which is 163.43% higher than the current price. The consensus rating is "Buy".

Price Target	$64.83
Price Target Difference	163.43%
Analyst Consensus	Buy
Analyst Count	7
Revenue Growth Forecast (5Y)	119.00%
EPS Growth Forecast (5Y)	n/a

Stock Splits

The last stock split was on February 11, 2019. It was a reverse split with a ratio of 0.0666666:1.

Last Split Date	Feb 11, 2019
Split Type	Reverse
Split Ratio	0.0666666:1

Scores

CLDX has an Altman Z-Score of 33.69 and a Piotroski F-Score of 3.

Altman Z-Score	33.69
Piotroski F-Score	3